FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969232106> ?p ?o ?g. }

• W1969232106 abstract "Introduction Neoadjuvant chemotherapy (NACT) is increasingly being used for the management of breast carcinomas including inflammatory breast carcinoma and locally advanced cancer. Testing for molecular markers (ER/PR/HER2) is generally performed on the pre-treatment biopsy sample. It is not known whether the histological type, grade and/or molecular profile of those tumour change as a result of chemotherapy. Potential changes particularly from negative to positive status may provide further treatment options for those patients. Materials & Method Patients who underwent NACT for primary and operable invasive carcinoma in the period between 2005 to 2009 were identified from the database of a single large UK tertiary referral breast unit. Comprehensive data on chemotherapy regimen, surgical treatment, pathological response and survival were collected. For residual invasive disease (partial pathological response), slides were reviewed and a representative block was selected and marked for tissue microarray (TMA) construction. TMA and pre treatment core biopsy sections, where available, were stained for ER/PR and HER2. Histological type and grade of invasive carcinoma were recorded for pre and post treatment samples for each patient. Results A total of 124 patients including 19 presenting as inflammatory carcinoma were included. Median age was 46yrs, IQ range = 41-53. Patients predominantly received anthracyclin-based therapy. Complete pathological response was achieved in 21.8% of patients. The commonest histological type on core biopsy was ductal carcinoma of no special type (n = 108, 63.9%) followed by lobular (7), mixed (5), metaplastic (2) and mucinous (2). There was a change in histological type in 14.9% of cases. Of the partial responders, grade was available on excision of 111 patients (additional 6 were not gradable). The histological grade was different between the core biopsy and final excision in 29 tumours (26%) including 10 upgrades and 19 downgrades (p Out of 83 ER stained paired pre and post tumour samples, 7 tumours (8.4%) changed profile from ER negative (Allred score 0/8) to positive (score 2 or above) including a strongly positive tumour (score 7/8) and 2 from positive to negative. Three out of 80 cases changed from PR negative to positive including a moderately positive case (6/8) whereas 2 changed from positive to negative. HER2 status changed from negative to positive in one patient and positive to negative in 2 /72 cases. Conclusion Significant changes in histological grade, type and molecular marker status occur following neoadjuvant chemotherapy. Tumours were more likely to be downgraded than upgraded following NACT. Changes in the ER, PR and HER2 status following chemotherapy occurred in 12%, 6.3% and 4.2% of cases respectively. This may have important implications in tailoring treatment options for patients that would otherwise be denied hormonal and/or Herceptin therapy if testing was solely done on the pre-treatment biopsy. Based on this data, we recommend repeat testing on residual carcinoma and prospective collection of data on management and outcome of those patients. Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-14-09." @default.
• W1969232106 created "2016-06-24" @default.
• W1969232106 creator A5002979606 @default.
• W1969232106 creator A5015824949 @default.
• W1969232106 creator A5036270120 @default.
• W1969232106 creator A5040782519 @default.
• W1969232106 creator A5041065594 @default.
• W1969232106 creator A5042893427 @default.
• W1969232106 creator A5061728338 @default.
• W1969232106 creator A5073056145 @default.
• W1969232106 creator A5088592323 @default.
• W1969232106 date "2013-12-15" @default.
• W1969232106 modified "2023-09-25" @default.
• W1969232106 title "Abstract P3-14-09: Should testing for estrogen receptor, progesterone receptor and HER2 be repeated following neoadjuvant chemotherapy?" @default.
• W1969232106 doi "https://doi.org/10.1158/0008-5472.sabcs13-p3-14-09" @default.
• W1969232106 hasPublicationYear "2013" @default.
• W1969232106 type Work @default.
• W1969232106 sameAs 1969232106 @default.
• W1969232106 citedByCount "0" @default.
• W1969232106 crossrefType "proceedings-article" @default.
• W1969232106 hasAuthorship W1969232106A5002979606 @default.
• W1969232106 hasAuthorship W1969232106A5015824949 @default.
• W1969232106 hasAuthorship W1969232106A5036270120 @default.
• W1969232106 hasAuthorship W1969232106A5040782519 @default.
• W1969232106 hasAuthorship W1969232106A5041065594 @default.
• W1969232106 hasAuthorship W1969232106A5042893427 @default.
• W1969232106 hasAuthorship W1969232106A5061728338 @default.
• W1969232106 hasAuthorship W1969232106A5073056145 @default.
• W1969232106 hasAuthorship W1969232106A5088592323 @default.
• W1969232106 hasConcept C121608353 @default.
• W1969232106 hasConcept C126322002 @default.
• W1969232106 hasConcept C142724271 @default.
• W1969232106 hasConcept C143998085 @default.
• W1969232106 hasConcept C207886595 @default.
• W1969232106 hasConcept C2775934546 @default.
• W1969232106 hasConcept C2776694085 @default.
• W1969232106 hasConcept C2777546739 @default.
• W1969232106 hasConcept C2778292576 @default.
• W1969232106 hasConcept C2780839634 @default.
• W1969232106 hasConcept C530470458 @default.
• W1969232106 hasConcept C71924100 @default.
• W1969232106 hasConcept C84606932 @default.
• W1969232106 hasConcept C98717036 @default.
• W1969232106 hasConceptScore W1969232106C121608353 @default.
• W1969232106 hasConceptScore W1969232106C126322002 @default.
• W1969232106 hasConceptScore W1969232106C142724271 @default.
• W1969232106 hasConceptScore W1969232106C143998085 @default.
• W1969232106 hasConceptScore W1969232106C207886595 @default.
• W1969232106 hasConceptScore W1969232106C2775934546 @default.
• W1969232106 hasConceptScore W1969232106C2776694085 @default.
• W1969232106 hasConceptScore W1969232106C2777546739 @default.
• W1969232106 hasConceptScore W1969232106C2778292576 @default.
• W1969232106 hasConceptScore W1969232106C2780839634 @default.
• W1969232106 hasConceptScore W1969232106C530470458 @default.
• W1969232106 hasConceptScore W1969232106C71924100 @default.
• W1969232106 hasConceptScore W1969232106C84606932 @default.
• W1969232106 hasConceptScore W1969232106C98717036 @default.
• W1969232106 hasLocation W19692321061 @default.
• W1969232106 hasOpenAccess W1969232106 @default.
• W1969232106 hasPrimaryLocation W19692321061 @default.
• W1969232106 hasRelatedWork W158571084 @default.
• W1969232106 hasRelatedWork W192510518 @default.
• W1969232106 hasRelatedWork W1965919107 @default.
• W1969232106 hasRelatedWork W1995871893 @default.
• W1969232106 hasRelatedWork W2023765926 @default.
• W1969232106 hasRelatedWork W2322682452 @default.
• W1969232106 hasRelatedWork W2334006558 @default.
• W1969232106 hasRelatedWork W2378550109 @default.
• W1969232106 hasRelatedWork W2408133893 @default.
• W1969232106 hasRelatedWork W2739693009 @default.
• W1969232106 hasRelatedWork W2789898434 @default.
• W1969232106 hasRelatedWork W2793609255 @default.
• W1969232106 hasRelatedWork W2898826204 @default.
• W1969232106 hasRelatedWork W2908948198 @default.
• W1969232106 hasRelatedWork W2973178425 @default.
• W1969232106 hasRelatedWork W2998363703 @default.
• W1969232106 hasRelatedWork W3030017313 @default.
• W1969232106 hasRelatedWork W3049436135 @default.
• W1969232106 hasRelatedWork W3090216115 @default.
• W1969232106 hasRelatedWork W3091559088 @default.
• W1969232106 isParatext "false" @default.
• W1969232106 isRetracted "false" @default.
• W1969232106 magId "1969232106" @default.
• W1969232106 workType "article" @default.